| Style | Citing Format |
|---|---|
| MLA | Rastegari A, et al.. "Pharmacogenetic Association of Kcnj11 (E23k) Variant With Therapeutic Response to Sulphonylurea (Glibenclamide) in Iranian Patients." International Journal of Diabetes in Developing Countries, vol. 35, no. 4, 2015, pp. 630-631. |
| APA | Rastegari A, Rabbani M, Sadeghi HM, Imani EF, Hasanzadeh A, Moazen F (2015). Pharmacogenetic Association of Kcnj11 (E23k) Variant With Therapeutic Response to Sulphonylurea (Glibenclamide) in Iranian Patients. International Journal of Diabetes in Developing Countries, 35(4), 630-631. |
| Chicago | Rastegari A, Rabbani M, Sadeghi HM, Imani EF, Hasanzadeh A, Moazen F. "Pharmacogenetic Association of Kcnj11 (E23k) Variant With Therapeutic Response to Sulphonylurea (Glibenclamide) in Iranian Patients." International Journal of Diabetes in Developing Countries 35, no. 4 (2015): 630-631. |
| Harvard | Rastegari A et al. (2015) 'Pharmacogenetic Association of Kcnj11 (E23k) Variant With Therapeutic Response to Sulphonylurea (Glibenclamide) in Iranian Patients', International Journal of Diabetes in Developing Countries, 35(4), pp. 630-631. |
| Vancouver | Rastegari A, Rabbani M, Sadeghi HM, Imani EF, Hasanzadeh A, Moazen F. Pharmacogenetic Association of Kcnj11 (E23k) Variant With Therapeutic Response to Sulphonylurea (Glibenclamide) in Iranian Patients. International Journal of Diabetes in Developing Countries. 2015;35(4):630-631. |
| BibTex | @article{ author = {Rastegari A and Rabbani M and Sadeghi HM and Imani EF and Hasanzadeh A and Moazen F}, title = {Pharmacogenetic Association of Kcnj11 (E23k) Variant With Therapeutic Response to Sulphonylurea (Glibenclamide) in Iranian Patients}, journal = {International Journal of Diabetes in Developing Countries}, volume = {35}, number = {4}, pages = {630-631}, year = {2015} } |
| RIS | TY - JOUR AU - Rastegari A AU - Rabbani M AU - Sadeghi HM AU - Imani EF AU - Hasanzadeh A AU - Moazen F TI - Pharmacogenetic Association of Kcnj11 (E23k) Variant With Therapeutic Response to Sulphonylurea (Glibenclamide) in Iranian Patients JO - International Journal of Diabetes in Developing Countries VL - 35 IS - 4 SP - 630 EP - 631 PY - 2015 ER - |